SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 1st, 2015 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 30, 2015, between Acura Pharmaceuticals, Inc., a New York corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • July 1st, 2015 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
Acura Pharmaceuticals, Inc., a New York corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell, through Roth Capital Partners, LLC (“Roth”), securities of the Company (the “Securities”), consisting of shares of common stock, par value $0.01 per share, directly to various investors (the “Investors”).
